Enlivex Therapeutics Ltd. (ENLV)
0.982
+0.04
(+4.47%)
USD |
NASDAQ |
Jan 20, 16:00
0.982
0.00 (0.00%)
After-Hours: 16:18
Enlivex Therapeutics Total Assets (Quarterly): 20.94M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd. | 97.84M |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | 26.17M |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.457M |
| Shareholders Equity (Quarterly) | 17.48M |
| Debt to Equity Ratio | 0.0401 |
| Current Ratio | 6.433 |
| Net Debt Paydown Yield | 0.11% |